A Zuccalà1, S Fiorenza, R Rapanà
1U.O. Nefrologia-Malpighi, Policlinico S.Orsola-Malpighi, Bologna, Italy. azuccala@orsola-malpighi.med.unibo.it
Patients with end-stage renal disease (ESRD) face significantly higher cardiovascular risk. Even minor kidney dysfunction, like microalbuminuria, elevates this risk through various mechanisms impacting atherosclerosis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: